(Q39496527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

review article

1 reference

title

Enalapril: a review of human pharmacology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

1 reference

H J Gomez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

V J Cirillo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J D Irvin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

30 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

13-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2994984%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-198500301-00004

8 October 2019

exact match

0 references

cites work

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade

1 reference

12 December 2020

Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor

1 reference

12 December 2020

Time Course and Effect of Sodium Intake on Vascular and Hormonal Responses to Enalapril (MK 421) in Normal Subjects

1 reference

12 December 2020

Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders

1 reference

12 December 2020

Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension

1 reference

12 December 2020

Captopril and Enalapril

1 reference

12 December 2020

Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.

1 reference

12 December 2020

Resolution of captopril-induced rash after substitution of enalapril

1 reference

12 December 2020

Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril)

1 reference

12 December 2020

Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

1 reference

12 December 2020

Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension

1 reference

12 December 2020

The physiological disposition and metabolism of enalapril maleate in laboratory animals

1 reference

12 December 2020

Coronary vascular actions of the converting enzyme inhibitor, enalapril

1 reference

12 December 2020

The Therapeutic use of a new Potassium-Sparing Diuretic, Amiloride, and a Converting Enzyme Inhibitor, Mk-421, in Preventing Hypokalemia Associated with Primary and Secondary Hyperaldosteronism

1 reference

12 December 2020

Systemic and renal effects of enalapril and its effects on cardiac mass

1 reference

12 December 2020

Kinetic and metabolic aspects of enalapril action

1 reference

12 December 2020

Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension

1 reference

12 December 2020

Plasma renin substrate concentration during chronic propranolol therapy

1 reference

12 December 2020

Enalapril (MK421) in the treatment of hypertension with renal artery stenosis

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521): disposition in man

1 reference

12 December 2020

The effect of enalapril on serum prolactin

1 reference

12 December 2020

Increased renal plasma flow in long-term enalapril treatment of hypertension

1 reference

12 December 2020

Effect of antihypertensive therapy on left ventricular function and myocardial perfusion at rest and during exercise

1 reference

12 December 2020

A new class of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Overall tolerance and safety of enalapril

1 reference

12 December 2020

Cardioprotective Effects of Enalapril in Acute Myocardial Ischemia

1 reference

12 December 2020

Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report

1 reference

12 December 2020

Cardiac and haemodynamic effects of enalapril

1 reference

12 December 2020

Mechanism for hypotensive action of angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Review of the Overall Experience of Captopril in Hypertension

1 reference

12 December 2020

Renal glycosuria and azotemia after enalapril maleate (MK-421)

1 reference

12 December 2020

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure

1 reference

12 December 2020

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

1 reference

12 December 2020

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system

1 reference

12 December 2020

Effects of enalapril, a new converting enzyme inhibitor, in hypertension

1 reference

12 December 2020

Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm

1 reference

12 December 2020

An overview of the clinical pharmacology of enalapril

1 reference

12 December 2020

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

1 reference

12 December 2020

Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment

1 reference

12 December 2020

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

1 reference

12 December 2020

A simplified radioimmunoassay for physiologically active angiotensin peptides [(1-8) octa- and (2-8) heptapeptides]

1 reference

12 December 2020

The clinical pharmacology of enalapril

1 reference

12 December 2020

Reversible leucopenia associated with angiotensin-converting-enzyme inhibitor MK 421

1 reference

12 December 2020

Effective dose range of enalapril in mild to moderate essential hypertension

1 reference

12 December 2020

Acute haemodynamic, hormonal and electrolyte effects and short-term clinical response to enalapril in heart failure

1 reference

12 December 2020

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

12 December 2020

Long-term clinical experience with enalapril in essential hypertension

1 reference

12 December 2020

Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.

1 reference

12 December 2020

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

1 reference

12 December 2020

"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors

1 reference

12 December 2020

Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects

1 reference

12 December 2020